Stockscreener 앱 받기
1.67
0.60%
0.01
전일 마감가:
$1.66
열려 있는:
$1.64
하루 거래량:
25,620
Relative Volume:
0.14
시가총액:
$20.47M
수익:
$34.75M
순이익/손실:
$-24.76M
주가수익비율:
-0.1392
EPS:
-12
순현금흐름:
$-50.91M
1주 성능:
-1.76%
1개월 성능:
+11.33%
6개월 성능:
-34.77%
1년 성능:
-80.65%
1일 변동 폭
$1.64
$1.69
1주일 범위
$1.61
$1.75
52주 변동 폭
$1.02
$16.81
Allurion Technologies Inc Stock (ALUR) Company Profile
명칭
Allurion Technologies Inc
전화
508-647-4000
주소
11 HURON DR STE 200, NATICK
ALUR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALUR
Allurion Technologies Inc
|
1.67 | 20.35M | 34.75M | -24.76M | -50.91M | -12.00 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
Allurion Technologies Inc Stock (ALUR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-14 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2024-10-02 | 개시 | TD Cowen | Buy |
| 2024-09-06 | 개시 | ROTH MKM | Buy |
| 2024-02-09 | 개시 | Jefferies | Buy |
Allurion Technologies Inc 주식(ALUR)의 최신 뉴스
Allurion Technologies (NYSE:ALUR) Shares Down 0.6% – Here’s What Happened - Defense World
Is Allurion Technologies Inc Equity Warrant a good long term investmentTake Profit Strategies & Big Gains Small Budget - earlytimes.in
Can Allurion Technologies Stock Hold Up When Markets Turn? - Trefis
Allurion extends rally despite $7.4M stock and warrants offering - MSN
Allurion Shares Jump 10.9% After FDA Progress and Debt Exchange Deal - MSN
Allurion Technologies (ALUR) director sells $4.9k in shares - Investing.com India
Allurion Technologies (ALUR) director sells $4.9k in shares By Investing.com - Investing.com UK
Dir Davin Sells 3,212 ($4.9K) Of Allurion Technologies Inc [ALUR] - TradingView
Allurion Technologies (ALUR) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Is Allurion Technologies Inc. Warrants each stock a good hedge against inflationTrade Entry Report & Smart Money Movement Tracker - Newser
How Allurion Technologies Inc. Warrants each stock behaves under inflation pressure2025 Top Gainers & Capital Efficient Trade Techniques - Newser
Why Allurion Technologies Inc. stock is a strong analyst pickWeekly Risk Summary & Safe Entry Momentum Stock Tips - Newser
Will Allurion Technologies Inc. Warrants each stock outperform Dow JonesQuarterly Performance Summary & Precise Entry and Exit Recommendations - Newser
How Allurion Technologies Inc. Equity Warrant stock valuations compare to rivalsMarket Activity Recap & Real-Time Market Trend Scan - Newser
How Allurion Technologies Inc. Warrants each stock responds to job market shiftsMarket Trend Summary & Accurate Trade Setup Notifications - Newser
Can Allurion Technologies Inc. Warrants each stock surprise markets with earnings2025 Stock Rankings & Consistent Profit Alerts - Newser
Why Allurion Technologies Inc. Equity Warrant stock is popular among millennialsPortfolio Value Summary & Weekly Setup with High ROI Potential - Newser
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session - Benzinga
How Allurion Technologies Inc. stock benefits from strong dollarJuly 2025 Weekly Recap & Capital Efficiency Focused Strategies - Newser
Shareholder Davin Family Nominee Tr 4/16/04 Files To Sell 3,212 Of Allurion Technologies Inc [ALUR] - TradingView
Is Allurion Technologies Inc. Warrants each stock supported by free cash flowPortfolio Gains Summary & Reliable Price Breakout Alerts - Newser
How Allurion Technologies Inc. Warrants each stock valuation compares with sectorMarket Growth Report & Reliable Trade Execution Plans - Newser
Allurion reports initial results on Allurion Program, tirzepatide combination - MSN
Allurion reports 23% weight loss combining balloon with low-dose GLP-1 By Investing.com - Investing.com South Africa
Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence - BioSpace
Allurion reports 23% weight loss, 14% lean mass gain on combining program with Tirzepatide - marketscreener.com
Allurion Reports 23% Weight Loss, 14% Lean Mass Gain On Combining Program With Tirzepatide - TradingView
Allurion reports 23% weight loss combining balloon with low-dose GLP-1 - Investing.com Australia
Allurion rises after strong weight-loss data from combination therapy - TradingView
Allurion (NYSE: ALUR) Posts 23% Weight Loss, 14% Lean Mass Gain With Low-Dose Tirzepatide - Stock Titan
Allurion Technologies (NYSE:ALUR) Given Neutral Rating at Chardan Capital - Defense World
Allurion Technologies’ (ALUR) Neutral Rating Reiterated at Chardan Capital - Defense World
Is the RiskReward Ratio Favorable for LWS Knitwear Limited in YEARTechnical Pattern Recognition & Reap the Rewards of Patience + Planning - earlytimes.in
Can Allurion Technologies Inc. Equity Warrant stock reach $100 price targetTrade Performance Summary & Smart Swing Trading Techniques - newser.com
Can Allurion Technologies Inc. Warrants each stock sustain revenue momentum - newser.com
Can Allurion Technologies Inc. stock hold up in economic slowdown2025 Volatility Report & Safe Capital Growth Plans - newser.com
Allurion Technologies’ Earnings Call: Progress Amid Challenges - MSN
Allurion Smart Capsule shows 20% weight reduction in new study By Investing.com - Investing.com Australia
Allurion Technologies Delays Q3 2025 Report Filing - MSN
Is Allurion Technologies Inc. Warrants each stock a buy for dividend portfoliosJuly 2025 Breakouts & Detailed Earnings Play Strategies - newser.com
Chardan Capital Maintains Allurion Technologies (ALUR) Neutral Recommendation - Nasdaq
Allurion Smart Capsule shows 20% weight reduction in new study - Investing.com
New Peer-Reviewed Publication Demonstrates Superior Weight Loss and Improved Body Composition with the Allurion Smart Capsule Combined with Lifestyle Intervention Compared to Lifestyle Intervention Alone - The Joplin Globe
Allurion (NYSE: ALUR) Reports 20% Weight Loss, Better Body Composition at 36 Weeks - Stock Titan
Allurion Technologies (ALUR) Receives Neutral Rating Confirmatio - GuruFocus
Why millennials buy Allurion Technologies Inc. stockInsider Buying & Short-Term Trading Alerts - newser.com
Allurion Technologies Inc (ALUR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
0.28%
자본화:
|
볼륨(24시간):